During the past decade, Florida Lipid Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Florida Lipid Institute" are "Homozygous Familial Hypercholesterolemia" (1 trials) and "Hypercholesterolemia" (1 trials). Many other conditions were trialed in "Florida Lipid Institute" in a lesser frequency.

Most popular intervention types in "Florida Lipid Institute" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Background Lipid Modifying Therapy (LMT)" (1 trials), "Evinacumab" (1 trials), "Lomitapide" (1 trials) and "Matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Florida Lipid Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Florida Lipid Institute". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Florida Lipid Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Florida Lipid Institute, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".